Cardiovascular health: MEPs respond to EU Safe Hearts Plan
On Wednesday, Parliament’s Public Health Committee adopted its response to the EU’s first ever cardiovascular health plan.
Interview: The evidence linking respiratory infections to cardiovascular disease is strong and growing
Prof Colin Russell, ESWI Chair and Co-Chair of the Steering Group on Prevention of Respiratory Infections, explains how a new Council Recommendation could enhance preventative health for at-risk groups.
Summary Report: IDC Stakeholder Community Meeting - 10 June 2026, Brussels
Key takeaways and next steps from the first in-person meeting of the IDC
Influenza vaccination attenuates acute myocardial infarction and stroke risk following influenza infection: a register-based, self-controlled case series study, Denmark, 2014 to 2025
Influenza infection conferred a transiently increased risk of first-time AMI and stroke. Vaccination substantially attenuated this risk, supporting its role in preventing cardiovascular complications after breakthrough infection.
Cardiovascular disease related to influenza infection and the protective role of influenza vaccination
Influenza vaccination significantly reduces major adverse cardiovascular events and mortality across high-risk cardiac populations.
News
Policy & Recommendations
Respiratory infections and long-term illness: a two-way street
The IDC kick-off meeting on 5 March was featured on the Vaccines Today news website.
Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heart
Abundant evidence has correlated influenza infection with cardiovascular disease, yet mechanisms linking infection with the heart remain poorly understood.
Influenza vaccination and the risk of myocardial infarction: a meta-epidemiology study
The association between influenza vaccination and the risk of myocardial infarction (MI) remains incompletely characterized, particularly in real-world populations.
